Jodi Karnell, Ph.D., is the senior director of research at Horizon Therapeutics, a global biotechnology company focused on the discovery, development and commercialization of medicines for people impacted by rare, autoimmune and severe inflammatory diseases. Dr. Karnell has over 14 years of experience working in the biotech industry across various programs. She earned her Ph.D. in immunology from the University of Pennsylvania and is passionate about research pertaining to b cells and the adaptive immune system.